Phase 2 Placebo-Controlled Study to Assess the Safety and Efficacy of ESK-001 in Active Systemic Lupus Erythematosus

Active, not recruiting

Plain-English translation of NCT05966480 on ClinicalTrials.gov ↗ · Source last updated April 2026 · How we translate trials

Phase 2 — Testing in a bigger group (up to a few hundred people) to see if the treatment actually works and is still safe.

Trial locations(169 sites)

United States

Investigator Site #1046, Anniston, Alabama

Investigator Site #1104, La Jolla, California

Investigator Site #1050, Los Alamitos, California

Investigator Site #1168, Mission Hills, California

Investigator Site #1174, Napa, California